
Terbinafine (1% w/w)
Active composition
Terbinafine inhibits squalene epoxidase, disrupting ergosterol synthesis in fungal cell membranes.
Medical applications
Gris ODT Cream contains Terbinafine 1% w/w, an antifungal agent belonging to the allylamine class, indicated for the topical treatment of superficial fungal infections of the skin. Terbinafine exerts its antifungal effect by inhibiting the enzyme squalene epoxidase, leading to a deficiency in ergosterol, an essential component of fungal cell membranes, thereby disrupting cell membrane synthesis and causing fungal cell death. Gris ODT Cream is effective against dermatophytes, yeasts, and molds responsible for conditions such as tinea corporis, tinea cruris, tinea pedis, and candidiasis. The cream formulation allows for easy application and rapid absorption, providing localized antifungal activity with minimal systemic exposure. It is intended for external use only and should be applied once or twice daily to the affected area after cleansing and drying the skin. Treatment duration varies depending on the infection type and severity but typically ranges from 2 to 4 weeks. Patients should be advised to avoid contact with eyes and mucous membranes and to discontinue use if irritation or hypersensitivity reactions occur. Gris ODT Cream is contraindicated in individuals with known hypersensitivity to Terbinafine or any cream excipients. Use during pregnancy and lactation should be under medical supervision.
Allylamine
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Gris ODT Cream may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Gris ODT Cream is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
No interaction found/established
Exercise Caution
No interaction found/established
Consult Doctor
No interaction found/established
Regular Checkup
0 reviews for Gris ODT Cream

Terbinafine (1% w/w)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
Terbinafine inhibits squalene epoxidase, disrupting ergosterol synthesis in fungal cell membranes.
Medical applications
Gris ODT Cream contains Terbinafine 1% w/w, an antifungal agent belonging to the allylamine class, indicated for the topical treatment of superficial fungal infections of the skin. Terbinafine exerts its antifungal effect by inhibiting the enzyme squalene epoxidase, leading to a deficiency in ergosterol, an essential component of fungal cell membranes, thereby disrupting cell membrane synthesis and causing fungal cell death. Gris ODT Cream is effective against dermatophytes, yeasts, and molds responsible for conditions such as tinea corporis, tinea cruris, tinea pedis, and candidiasis. The cream formulation allows for easy application and rapid absorption, providing localized antifungal activity with minimal systemic exposure. It is intended for external use only and should be applied once or twice daily to the affected area after cleansing and drying the skin. Treatment duration varies depending on the infection type and severity but typically ranges from 2 to 4 weeks. Patients should be advised to avoid contact with eyes and mucous membranes and to discontinue use if irritation or hypersensitivity reactions occur. Gris ODT Cream is contraindicated in individuals with known hypersensitivity to Terbinafine or any cream excipients. Use during pregnancy and lactation should be under medical supervision.
Allylamine
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Gris ODT Cream may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Gris ODT Cream is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
No interaction found/established
Exercise Caution
No interaction found/established
Consult Doctor
No interaction found/established
Regular Checkup
0 reviews for Gris ODT Cream















